Showing results (1821-1830 of 3,162) with videos related to

Sort By:
Pageof 317
The Journal of Antimicrobial Chemotherapy|January 29, 2014
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12)Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing methodRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1990
The reliability of palpation in the assessment of tumoursJ C Watkinson, D Johnston, N Jones, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance programHelio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Animals : an Open Access Journal From MDPI|December 9, 2023
Estimation of In Vitro True Digestibility and Fiber Degradation from Feedstuff Fiber Composition When Incubated in Equine Fecal InoculumRyon W Springer, Nichole M Cherry, Randel H Raub, et al.
Psychological Methods|December 14, 2023
Using Bayesian item response theory for multicohort repeated measure design to estimate individual latent change scoresChun Wang, Ruoyi Zhu, Paul K Crane, et al.
International Journal of Antimicrobial Agents|August 23, 2001
Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and developmentA M Fix, M A Pfaller, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|August 2, 2002
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000)Jeffrey T Kirby, Alan H Mutnick, Ronald N Jones, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|April 6, 2001
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance studyH S Sader, R N Jones, C H Ballow, et al.
Pageof 317